CoChat
Sign Up
Cited by 55T-cell and Retrovirus StudiesHIV Research and TreatmentInfectious Diseases and Tuberculosis

The DOI matches its Crossref record.

PLASMAPHERESIS IN TREATMENT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I ASSOCIATED MYELOPATHY

Matsuo, Hidenori, Tsujihata, Mitsuhiro, Satoh, Akira, Shirabe, Susumu, Nakamura, Tatsufumi, Kinoshita, Ikuo, Tomita, Itsuro, Shibayama, Kohji, Nagataki, Shigenobu·1988·The Lancet
DOI 10.1016/s0140-6736(88)90525-9
Open this paper in CoChat — free account

Abstract

In 11 of 18 patients with human T-lymphotropic virus type-I (HTLV-I) associated myelopathy (HAM) gait, sensory, and/or sphincter disturbance improved with plasmapheresis (4 to 6 sessions in 2 weeks), and the effects were maintained for 2 to 4 weeks. Plasmapheresis lowered the titre of HTLV-I antibody in serum but not in cerebrospinal fluid, and change of HTLV-I antibody titres did not correlate with the effects of plasmapheresis. These results suggest that plasmapheresis is useful treatment, at least in producing a temporary improvement, in patients with HAM, and that some humoral factor(s), but not HTLV-I antibody, may be important in the pathogenesis of HAM.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(88)90525-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Plasmapheresis was demonstrated to improve gait and reduce sensory and sphincter disturbances in 11 out of 18 patients with 4-6 sessions in a two-week period.

    “Plasmapheresis was demonstrated to improve gait and reduce sensory and sphincter disturbances in 11 out of 18 patients with 4–6 sessions in a two-week period [256].”

    From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [256]

  • Plasmapheresis may offer a temporary improvement in HAM patients.

    “Furthermore, a lower serum HTLV-1 antibody titre was observed, suggesting that plasmapheresis may offer a temporary improvement in HAM patients.”

    From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [256]

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 21

  1. Osame, 1986, HTLV-I associated myelopathy. a new clinica. entity, Lancet, i, 1031, 10.1016/S0140-6736(86)91298-5 · DOI
  2. Osame, 1987, Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia like cells, Ann Neurol, 21, 117, 10.1002/ana.410210203 · DOI
  3. Gessain, 1985, Antibodies to human T-lymphotropic virus type I in patients with spastic paraparesis, Lancet, 407, 10.1016/S0140-6736(85)92734-5 · DOI
  4. Vemant, 1987, Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I : a clinical and sero-epidemiological study of 25 cases, Ann Neurol, 21, 123, 10.1002/ana.410210204 · DOI
  5. Zaninovic, 1986, El virus HTLV-I como posible causa de la paraparesia espatica del Pacifico, Colombia Medica, 17, 2
  6. Roman, 1987, Human T-lymphotropic virus type I antibodies in the serum of patients with tropical spastic paraparesis in the Seychelles, Arch Neurol, 44, 605, 10.1001/archneur.1987.00520180029011 · DOI
  7. Rogers-Johnson, 1986, HTLV-I and HTLV-III antibodies in tropical spastic paraparesis, Lancet, ii, 1247
  8. Bartholomew, 1986, HTLV-I and tropical spastic paraparesis, Lancet, ii, 99, 10.1016/S0140-6736(86)91626-0 · DOI
  9. Johnson, 1987, Myelopathy and retroviruses, Ann Neurol, 21, 113, 10.1002/ana.410210202 · DOI
  10. Roman, 1987, Retrovirus associated myelopathies, Arch Neurol, 44, 659, 10.1001/archneur.1987.00520180073022 · DOI
  11. Lockwood, 1976, Immonosuppression and plasma exchange in the treatment of Goodpasture's syndrome, Lancet, i, 711, 10.1016/S0140-6736(76)93089-0 · DOI
  12. Jones, 1976, Plasmapheresis in the management of acute systemic lupus erythematosus?, Lancet, i, 709, 10.1016/S0140-6736(76)93088-9 · DOI
  13. Hamilton, 1980, Plasma exchange in SLE, Lancet, i, 1249, 10.1016/S0140-6736(80)91705-5 · DOI
  14. Dau, 1977, Plasmapheresis and immunosuppresive drug therapy in myasthenia gravis, N Engl J Med, 297, 1134, 10.1056/NEJM197711242972102 · DOI
  15. Schauf, 1979, Concerning the application of plasmapheresis to multiple sclerosis, Plasma Ther, 1, 33
  16. Dau, 1980, Plasmapheresis in multiple sclerosis preliminary findings, Neurology, 30, 1023, 10.1212/WNL.30.10.1023 · DOI
  17. Weiner, 1980, Plasmapheresis in multiple sclerosis: preliminary study, Neurology, 30, 1029, 10.1212/WNL.30.10.1029 · DOI
  18. Laemmli, 1970, Cleavages of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 · DOI · Paper page
  19. Taguchi, 1983, Enzyme-linked immunosorbent assay of antibodies to adult T-cell leukemia-associated antigens, Cann, 74, 185
  20. Ikeda, 1984, A new agglutination test for serum antibodies to adult T-cell leukemia virus, Gann, 75, 845
  21. Stefoski, 1982, Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis, Neurology, 32, 904, 10.1212/WNL.32.8.904 · DOI

Cited by

Sorted by citations

Metadata

Authors
Matsuo, H., Tsujihata, M., Satoh, A., Shirabe, S., Nakamura, T., Kinoshita, I., Tomita, I., Shibayama, K., & Nagataki, S.
Affiliations
Nagasaki University (JP)
ORCID
Venue
The Lancet
Publisher
Elsevier BV
Published
1988-11
Volume
332
Issue
8620
Pages
1109-1113
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(88)90525-9
OpenAlex
W2019526141
Cited by
55
References
0
Citations by year
2026: 1 · 2024: 1 · 2021: 1 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 2
FWCI
1.35
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
plasmapheresis, tropical spastic paraparesis, HTLV-1, cerebrospinal fluid, humoral immune factors, pathogenesis, gait disturbance, sensory disturbances, sphincter dysfunction
MeSH terms
Adult, Aged, Antibodies, Viral, Anus Diseases, Evaluation Studies as Topic, Female, Deltaretrovirus Infections, Humans, Locomotion, Male, Middle Aged, Movement Disorders, Nervous System Diseases, Plasmapheresis, Sensation, Spinal Cord Diseases, Time Factors, Human T-lymphotropic virus 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review